Alao, Richel Mae .

HRN: 04-32-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2025
AMPICILLIN 1GM (VIAL)
04/27/2025
05/03/2025
IV
2g
Q6
G1P0 PU 39 0/7 Weeks AOG By LMP; PROM X 15hrs
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: